Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196138
Max Phase: Preclinical
Molecular Formula: C19H15ClN6S
Molecular Weight: 394.89
Associated Items:
ID: ALA5196138
Max Phase: Preclinical
Molecular Formula: C19H15ClN6S
Molecular Weight: 394.89
Associated Items:
Canonical SMILES: Nc1ccc(Nc2nc(Nc3ccc(-c4ccsc4)cn3)ncc2Cl)cc1
Standard InChI: InChI=1S/C19H15ClN6S/c20-16-10-23-19(26-18(16)24-15-4-2-14(21)3-5-15)25-17-6-1-12(9-22-17)13-7-8-27-11-13/h1-11H,21H2,(H2,22,23,24,25,26)
Standard InChI Key: YJNKDMJBFHJGJJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 394.89 | Molecular Weight (Monoisotopic): 394.0767 | AlogP: 5.32 | #Rotatable Bonds: 5 |
Polar Surface Area: 88.75 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.04 | CX Basic pKa: 4.63 | CX LogP: 4.78 | CX LogD: 4.78 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.40 | Np Likeness Score: -1.84 |
1. Chen X, Yan Y, Du J, Shen X, He C, Pan H, Zhu J, Liu X.. (2022) Non-peptidyl non-covalent cathepsin C inhibitoEEr bearing a unique thiophene-substituted pyridine: Design, structure-activity relationship and anti-inflammatory activity in vivo., 236 [PMID:35429909] [10.1016/j.ejmech.2022.114368] |
Source(1):